Terence Wong, MD PhD

Professor of Radiology
Professor in Medicine
Member of the Duke Cancer Institute
Address: Box 3949 Med Ctr
Durham, NC 27710
Phone: (919) 684-7748
Email: terence.wong@duke.edu

Research Interests

1. Anatomic/functional oncologic Imaging: SPECT/CT, PET/CT, novel PET radiotracers

2. Radiotheranostics, Radionuclide therapy of cancer, Radiation Therapy Planning

3. Imaging biomarkers for guiding treatment strategies

4. Multicenter clinical trial development (NCI National Clinical Trials Network)

Publications

Morse, Michael A., et al. “Tumor protein p53 mutation in archived tumor samples from a 12-year survivor of stage 4 pancreatic ductal adenocarcinoma may predict long-term survival with DeltaRex-G: A case report and literature review.Molecular and Clinical Oncology, vol. 15, no. 3, Sept. 2021, p. 186. Epmc, doi:10.3892/mco.2021.2348.

Howard, Brandon A., and Terence Z. Wong. “18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies.Radiologic Clinics of North America, vol. 59, no. 5, Sept. 2021, pp. 737–53. Epmc, doi:10.1016/j.rcl.2021.06.001.

Shah, Manisha H., et al. “Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw, vol. 19, no. 7, July 2021, pp. 839–68. Pubmed, doi:10.6004/jnccn.2021.0032.

James, Olga G., et al. “Evaluating Alzheimer Disease With Flortaucipir and Florbetapir PET: A Clinical Case Series.Clinical Nuclear Medicine, vol. 46, no. 7, July 2021, pp. 605–08. Epmc, doi:10.1097/rlu.0000000000003493.

Oldan, J. D., et al. “Complete Evaluation of Dementia: PET and MRI Correlation and Diagnosis for the Neuroradiologist.Ajnr. American Journal of Neuroradiology, vol. 42, no. 6, June 2021, pp. 998–1007. Epmc, doi:10.3174/ajnr.a7079.

Vapiwala, Neha, et al. “Phase III study of local or systemic therapy INtensification DIrected by PET in prostate CAncer patients with post-prostaTEctomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191.Journal of Clinical Oncology, vol. 39, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2021, pp. TPS5098–TPS5098. Crossref, doi:10.1200/jco.2021.39.15_suppl.tps5098.

Eads, Jennifer Rachel, et al. “A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of a safety run-in—A trial of the ECOG-ACRIN Cancer Research Group (EA2174).Journal of Clinical Oncology, vol. 39, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2021, pp. 4064–4064. Crossref, doi:10.1200/jco.2021.39.15_suppl.4064.

Vapiwala, Neha, et al. “PET-directed local or systemic therapy intensification in prostate cancer patients with post-prostatectomy biochemical recurrence: A trial of the ECOG-ACRIN Cancer Research Group (EA8191).Journal of Clinical Oncology, vol. 39, no. 6_suppl, American Society of Clinical Oncology (ASCO), 2021, pp. TPS267–TPS267. Crossref, doi:10.1200/jco.2021.39.6_suppl.tps267.